Emerald Acquisition »

United Therapeutics Corporation shares owned by Emerald Acquisition

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Emerald Acquisition from 13F filings

Historical chart of Emerald Acquisition investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Emerald Acquisition consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Emerald Acquisition

Quarter filed Position value Share count Share price at filing
2016-09-30 $56M 472k 118.07
2016-06-30 $47M 447k 105.91

More positions owned by Emerald Acquisition

Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Taiwan Semiconductor Mfg (TSM)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Citigroup (C)
Oracle Corporation (ORCL)
Pfizer (PFE)
Wells Fargo & Company (WFC)
Alphabet Inc Class A cs (GOOGL)
Procter & Gamble Company (PG)
Visa (V)
Facebook Inc cl a (META)
Bank of America Corporation (BAC)

View all positions for Emerald Acquisition

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation